VSee Health, Inc. Cash Flow Conversion Efficiency
VSee Health, Inc. cash flow conversion efficiency. Based on the latest financial reports, VSee Health, Inc. (VSEE) has a cash flow conversion efficiency ratio of -0.353x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.93 Million) by net assets ($5.45 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of VSee Health, Inc. (2020–2025)
Cash flow conversion efficiency of VSee Health, Inc. from 2020 to 2025. This chart illustrates how VSee Health, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View VSEE share price today for real-time trading data and today's change.
VSee Health, Inc. Cash Flow Conversion Ratio Explained
VSee Health, Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
VSee Health, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of VSee Health, Inc. ranked by their cash flow conversion efficiency. Also see how much is VSee Health, Inc. worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Prostatype Genomics AB
ST:PROGEN
|
-0.234x |
|
GOLDSTONE RES LTD. LS-01
F:GVL1
|
N/A |
|
GenixPharmaceucticals Corporation
V:GENX
|
0.011x |
|
Fort St James Nickel Corp
V:FTJ
|
0.010x |
|
Gemfields Plc
LSE:GEM
|
0.044x |
|
Real Estate Investors PLC
LSE:RLE
|
0.016x |
|
Tinybuild Inc
LSE:TBLD
|
0.161x |
|
BLENDER BITES LTD.
F:JL4
|
-0.034x |
Annual Cash Flow Conversion Efficiency for VSee Health, Inc. (2020–2025)
The table below shows the annual cash flow conversion efficiency of VSee Health, Inc. from 2020 to 2025. Review VSee Health, Inc. (VSEE) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $5.45 Million | $-3.45 Million | -0.632x | -100.20% |
| 2024-12-31 | $-18.49K | $-5.79 Million | 313.151x | +212737.67% |
| 2023-12-31 | $-4.30 Million | $-632.60K | 0.147x | -99.98% |
| 2022-12-31 | $-2.03K | $-1.45 Million | 714.714x | +13504518.22% |
| 2021-12-31 | $113.39 Million | $-600.11K | -0.005x | -100.41% |
| 2020-12-31 | $614.49K | $789.12K | 1.284x | -- |
About VSee Health, Inc.
VSee Health, Inc. provides telehealth care solutions in the United States. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. It also provides telehealth software building blocks, such as patient en… Read more